Breaking News Instant updates and real-time market news.

WMT

Walmart

$97.89

-0.74 (-0.75%)

, AMZN

Amazon.com

$1,881.94

-5.56 (-0.29%)

12:42
08/18/18
08/18
12:42
08/18/18
12:42

May be time to sell Walmart, Barron's says

In a follow-up story, Barron's notes that while Walmart's (WMT) online division is growing like Amazon (AMZN) and sparking big gains for shares, the giant retailer could soon begin exhibiting another Amazon trait, namely increased earnings risk as it sacrifices profit margins for growth. Overseas trade scuffles add to that risk and it may be time to sell, Jack Hough writes in this week's edition of Barron's. Reference Link

WMT

Walmart

$97.89

-0.74 (-0.75%)

AMZN

Amazon.com

$1,881.94

-5.56 (-0.29%)

  • 13

    Sep

WMT Walmart
$97.89

-0.74 (-0.75%)

08/17/18
MSCO
08/17/18
NO CHANGE
Target $98
MSCO
Equal Weight
Walmart price target raised to $98 from $93 at Morgan Stanley
Morgan Stanley analyst Simeon Gutman said the strength of Walmart (WMT) Q2 U.S. same-store sales shows the brand is reaching new customers and succeeding in new categories. He added that, perhaps, the comp strength is a sign that the company is reaching into Amazon's (AMZN) higher income consumer base and said the full year goal of 40% e-commerce growth now seems achievable. Following the report, Gutman increased his price target on Walmart shares to $98, though he maintains an Equal Weight rating, stating that he sees comps slowing to less than 2% as its greatest near-term risk.
08/17/18
JPMS
08/17/18
NO CHANGE
Target $103
JPMS
Neutral
Walmart price target raised to $103 from $87 at JPMorgan
JPMorgan analyst Christopher Horves maintained a Neutral rating on Walmart but raised his price target to $103 after the company "shattered" expectations with its strong U.S. comp in over 10 years. In a research note to investors, Horvers says that several years of e-commerce initiatives are paying off, but likely at the expense of medium-term profits and that Walmart's large market share and mix in the lower-growth grocery category make the transition more difficult from a financial perspective.
08/17/18
RBCM
08/17/18
NO CHANGE
Target $102
RBCM
Sector Perform
Walmart price target raised to $102 from $90 at RBC Capital
RBC Capital analyst Scot Ciccarelli raised his price target on Walmart to $102 after its reported comps of 4.5% marked the biggest increase in 10 years. The analyst notes that while margins are declining from investments in pricing, labor, and technology - costs that will not go away soon - the spending can produce higher leverage. Ciccarelli keeps his Sector Perform rating on Walmart, saying the valuation multiple of 20-times expected EBIT seems expensive, but would look for an opportunity to become more constructive based on the company's improvements.
08/17/18
ARGS
08/17/18
NO CHANGE
Target $112
ARGS
Buy
Walmart price target raised to $112 from $100 at Argus
Argus analyst Chris Graja raised his price target on Walmart (WMT) to $112, citing the company's decade-best Q2 comps growth and a positive update on its e-commerce business, which grew by 40% in Q1. Graja also notes that online grocery sales were strong, as the department delivered its best comps growth in 9 years to retain its competitive position against Amazon's (AMZN) Whole Foods unit. The analyst keeps his Buy rating on Walmart and contends that the company is immune to the primary risk of "irrelevance" for retailers, stating that it plays an "important" role in the economy with its buying power and "logistical prowess".
AMZN Amazon.com
$1,881.94

-5.56 (-0.29%)

08/10/18
WEDB
08/10/18
INITIATION
Target $75
WEDB
Neutral
Kohl's initiated with a Neutral at Wedbush
Wedbush analyst Jen Redding initiated Kohl's (KSS) with a Neutral rating and $75 price target, telling investors that she views Kohl's as a compelling story and sees opportunities for improvement in categories like private label, active and women's, and says Kohl's Rewards and Amazon (AMZN) pilots as potential catalysts. Longer term, Redding favors the name and sees shares of U.S.-focused retailers like Kohl's, Dillard's (DDS), Burlington Stores (BURL) and American Eagle (AEO) as good options in a year of a strong dollar.
08/13/18
PIPR
08/13/18
NO CHANGE
Target $2100
PIPR
Overweight
Piper believes Amazon's ad business should be valued at $150B-$190B
Amazon.com's advertising business "has been quietly growing into a massive driver of current and future profitability," Piper Jaffray analyst Michael Olson tells investors in a research note. The analyst estimates that in 2018, Amazon advertising revenue will be around $8B, potentially contributing greater than $3B to operating profit. By 2020, he expects Amazon ad revenue of $16B and by 2021, he believes it is highly likely that profits contributed from advertising will exceed those from Amazon Web Services. Applying an advertising comp multiple of 16 times to estimated 2020 Amazon advertising operating income suggests an ad business that should be valued at $150B-$190B, Olson contends. As such, he believes investors "should be focused on Amazon advertising now." The analyst reiterates an Overweight rating on Amazon shares with a $2,100 price target. The stock closed Friday down $12.22 to $1,886.30.
08/13/18
08/13/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. GOLDMAN SACHS CUTS ALNYLAM TO BUY: Goldman Sachs analyst Terence Flynn downgraded Alnylam (ALNY) to Buy from Conviction Buy. The analyst also lowered his price target for the shares to $155 from $193. Flynn said the lack of cardio data in the approved U.S. label for Onpattro is disappointing and could represent a disadvantage versus Pfizer's (PFE) competitor drug Tafamadis. Piper Jaffray analyst Edward Tenthoff recommended buying shares of Alnylam Pharmaceuticals on weakness following the approval of Onpattro. Morgan Stanley analyst David Lebowitz lowered his price target to $93, Nomura Instinet analyst Christopher Marai lowered his price target to $73, and Stifel analyst Paul Matteis maintained a Buy rating but cut his price target to $123 from $125 and slightly lowered his revenue ramp for the drug based on modestly reduced share in mixed-phenotype haTTR patients and lower share in cardiac-only haTTR patients. B. Riley FBR analyst Madhu Kumar raised his price target to $230. RUBIUS THERAPEUTICS INITIATED AT MULTIPLE FIRMS: Rubius Therapeutics (RUBY) was initiated with an Outperform at Leerink, an Overweight at JPMorgan and Morgan Stanley, as well as a Buy at Jefferies. PIPER JAFFRAY SAYS AMAZON AD BUSINESS GROWING INTO PROFIT DRIVER: Amazon's (AMZN) advertising business "has been quietly growing into a massive driver of current and future profitability," Piper Jaffray analyst Michael Olson told investors in a research note. Applying an advertising comp multiple of 16 times to estimated 2020 Amazon advertising operating income suggests an ad business that should be valued at $150B-$190B, Olson contended. IMPERIAL CAPITAL CUTS NETFLIX PRICE TARGET TO $494: Imperial Capital analyst David Miller lowered his price target for Netflix (NFLX) to $494 after he slightly reduced his global subscriber estimates. The analyst said that in the "interest of being conservative," he decreased his fiscal 2018 global subscriber estimate to 141.2M from 141.4M and fiscal 2019 global subscriber estimate to 164.4M from 166.3M. DISH DOWNGRADED TO SELL AT MOFFETTNATHANSON: MoffettNathanson analyst Craig Moffett downgraded Dish (DISH) to Sell from Neutral with a price target of $29 and noted that while the reported Q2 business conditions in the core satellite TV business were "genuinely better" amid reduced churn and slower subscriber losses, the Spectrum segment -- which holds "all" of the company's equity value -- is worse.

TODAY'S FREE FLY STORIES

MSFT

Microsoft

$113.66

-1.04 (-0.91%)

, ADBE

Adobe

$261.32

0.47 (0.18%)

11:09
09/24/18
09/24
11:09
09/24/18
11:09
Hot Stocks
Microsoft, Adobe, SAP announce Open Data Initiative »

The CEOs of Adobe (ADBE),…

MSFT

Microsoft

$113.66

-1.04 (-0.91%)

ADBE

Adobe

$261.32

0.47 (0.18%)

SAP

SAP

$122.23

0.59 (0.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 25

    Sep

  • 21

    Oct

  • 22

    Oct

  • 24

    Oct

  • 25

    Oct

  • 28

    Oct

  • 28

    Nov

  • 03

    Mar

FCX

Freeport McMoRan

$14.38

-0.22 (-1.51%)

11:05
09/24/18
09/24
11:05
09/24/18
11:05
Options
Freeport McMoRan call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:05
09/24/18
09/24
11:05
09/24/18
11:05
General news
4-Week Bill Announcement Offering Amount data reported »

4-Week Bill Announcement…

MCD

McDonald's

$163.93

-0.23 (-0.14%)

11:02
09/24/18
09/24
11:02
09/24/18
11:02
Hot Stocks
McDonald's International Lead Markets & Chief Restaurant Officer Goare to retire »

McDonald's announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$290.57

-1.46 (-0.50%)

11:01
09/24/18
09/24
11:01
09/24/18
11:01
Periodicals
White House accepts Rod Rosenstein's resignation, Bloomberg reports »

Following an Axios report…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$290.57

-1.46 (-0.50%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:00
09/24/18
09/24
11:00
09/24/18
11:00
General news
FX Action: USD-JPY »

FX Action: USD-JPY…

NTR

Nutrien

$57.09

-0.15 (-0.26%)

10:58
09/24/18
09/24
10:58
09/24/18
10:58
Hot Stocks
Nutrien announces Jochen Tilk will step down as Executive Chair »

Nutrien announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

NTNX

Nutanix

$43.00

-3.55 (-7.63%)

, MSFT

Microsoft

$113.86

-0.84 (-0.73%)

10:56
09/24/18
09/24
10:56
09/24/18
10:56
Downgrade
Nutanix, Microsoft, VMware rating change  »

Nutanix downgraded to…

NTNX

Nutanix

$43.00

-3.55 (-7.63%)

MSFT

Microsoft

$113.86

-0.84 (-0.73%)

VMW

VMware

$153.86

1.86 (1.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 25

    Sep

  • 10

    Oct

  • 11

    Oct

  • 16

    Oct

  • 21

    Oct

  • 22

    Oct

  • 24

    Oct

  • 25

    Oct

  • 28

    Oct

  • 29

    Oct

  • 28

    Nov

  • 06

    Dec

  • 10

    Dec

  • 03

    Mar

IONS

Ionis Pharmaceuticals

$50.45

1.34 (2.73%)

, ALNY

Alnylam

$92.42

-2.17 (-2.29%)

10:56
09/24/18
09/24
10:56
09/24/18
10:56
Recommendations
Ionis Pharmaceuticals, Alnylam analyst commentary  »

Ionis platelet issue now…

IONS

Ionis Pharmaceuticals

$50.45

1.34 (2.73%)

ALNY

Alnylam

$92.42

-2.17 (-2.29%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

  • 06

    Oct

  • 27

    Nov

10:55
09/24/18
09/24
10:55
09/24/18
10:55
General news
Treasury Action: yields reverted lower »

Treasury Action: yields…

TRU

TransUnion

$74.19

-0.11 (-0.15%)

10:50
09/24/18
09/24
10:50
09/24/18
10:50
Options
Notable call write in TransUnion »

Notable call write in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

  • 21

    Oct

  • 23

    Oct

10:50
09/24/18
09/24
10:50
09/24/18
10:50
General news
U.S. Dallas Fed manufacturing index dropped 2.8 points to 28.1 in September »

U.S. Dallas Fed…

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$290.74

-1.29 (-0.44%)

10:46
09/24/18
09/24
10:46
09/24/18
10:46
Technical Analysis
Technical Take: SPDR S&P 500 ETF nears session lows »

The SPDR S&P 500 ETF…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$290.74

-1.29 (-0.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

P

Pandora

$9.43

0.35 (3.85%)

, SIRI

Sirius XM

$6.55

-0.425 (-6.10%)

10:45
09/24/18
09/24
10:45
09/24/18
10:45
Downgrade
Pandora, Sirius XM rating change  »

Pandora downgraded to…

P

Pandora

$9.43

0.35 (3.85%)

SIRI

Sirius XM

$6.55

-0.425 (-6.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 27

    Sep

10:45
09/24/18
09/24
10:45
09/24/18
10:45
General news
Breaking General news story  »

4-Week Bill Announcement…

NBIX

Neurocrine

$121.55

1.7 (1.42%)

10:45
09/24/18
09/24
10:45
09/24/18
10:45
Conference/Events
Neurocrine has a conference call hosted by JPMorgan »

JPMorgan Analyst Rama…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$291.02

-1.01 (-0.35%)

10:40
09/24/18
09/24
10:40
09/24/18
10:40
Periodicals
Deputy AG Rod Rosenstein verbally resigns to John Kelly, Axios reports »

Deputy Attorney General…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$291.02

-1.01 (-0.35%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLF

Cleveland-Cliffs

$12.47

0.31 (2.55%)

10:40
09/24/18
09/24
10:40
09/24/18
10:40
Options
Cleveland Cliffs calls active as shares move to 52-week highs »

Cleveland Cliffs calls…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

AMEH

Apollo Medical

$17.73

1.11 (6.68%)

10:39
09/24/18
09/24
10:39
09/24/18
10:39
Hot Stocks
Breaking Hot Stocks news story on Apollo Medical »

Apollo Medical Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:37
09/24/18
09/24
10:37
09/24/18
10:37
General news
Dallas Fed Mfg Survey General Activity Index data reported »

September Dallas Fed Mfg…

AMEH

Apollo Medical

$17.73

1.11 (6.68%)

10:34
09/24/18
09/24
10:34
09/24/18
10:34
Hot Stocks
Breaking Hot Stocks news story on Apollo Medical »

Apollo Medical Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CZR

Caesars

$10.53

-0.25 (-2.32%)

10:30
09/24/18
09/24
10:30
09/24/18
10:30
Recommendations
Caesars analyst commentary  »

Caesars defended at…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

USO

United States Oil Fund

$15.20

0.25 (1.67%)

10:30
09/24/18
09/24
10:30
09/24/18
10:30
Options
30K US Oil Fund Oct 14 - 15 call spreads trade at 74c »

30K US Oil Fund Oct 14 -…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JD

JD.com

$25.38

-1.1 (-4.15%)

10:25
09/24/18
09/24
10:25
09/24/18
10:25
Hot Stocks
JD.com drops as new WeChat messages emerge following CEO's rape accusations »

Shares of JD.com (JD)…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALXN

Alexion

$126.66

4.69 (3.85%)

10:24
09/24/18
09/24
10:24
09/24/18
10:24
Recommendations
Alexion analyst commentary  »

Piper 'incrementally…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 18

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.